Lung Function Decline According to Clinical Course in Nontuberculous Mycobacterial Lung Disease.

Chest

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address:

Published: December 2016

Background: There are few data regarding the impact of nontuberculous mycobacterial lung disease (NTM-LD) on lung function during the clinical course of disease. This study aimed to assess the impact of NTM-LD on lung function decline.

Methods: Treatment outcomes and spirometry data at diagnosis and at least three years later were obtained from 358 patients who were diagnosed with NTM-LD between January 1999 and November 2011 using the prospective NTM registry cohort. For analysis, patients were divided into three groups: those observed without treatment, those who had treatment success, and those in whom treatment failed.

Results: The treatment-failure group (n = 68) had a significantly more rapid decline in FEV and FVC compared with the observation (n = 118) and treatment-success (n = 172) groups (-52.2, -30.8, and -28.2 mL/y, respectively; P = .023 for FEV decline; -50.4, -28.8, and -26.0 mL/y, respectively; P = .002 for FVC decline). After adjusting for confounding factors, patients with treatment failure had greater FEV and FVC declines than did those observed without treatment (adjusted P = .026 for FEV decline; adjusted P = .022 for FVC decline) or those treated successfully (adjusted P = .004 for FEV decline; adjusted P = .002 for FVC decline). Patients treated successfully had declines in FEV and FVC similar to those in the observation group.

Conclusions: The change of lung function was variable over a median 5-year follow-up period. Treatment failure was associated with a substantial decline in lung function in NTM-LD.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2016.06.005DOI Listing

Publication Analysis

Top Keywords

lung function
20
adjusted p =
16
fev fvc
12
fev decline
12
fvc decline
12
decline
9
clinical course
8
nontuberculous mycobacterial
8
mycobacterial lung
8
lung disease
8

Similar Publications

We investigated the associations of ongoing, chronic stress exposure and stress appraisal on vascular endothelial function (VEF) in young adults. In 72 healthy young adults (74% female; age = 25±1 y), we assessed chronic stress exposure and appraisal with a measure that quantified chronic stress exposure and chronic stress appraisal related to 8 specific stressors over the last year. Participants completed the perceived stress scale (PSS) as a measure of global, proximal stress appraisal.

View Article and Find Full Text PDF

Physiological responses derived from audiovisual perception during assisted driving are associated with the regulation of the autonomic nervous system (ANS), especially in emergencies. However, the interaction of event-related brain activity and the ANS regulating peripheral physiological indicators (i.e.

View Article and Find Full Text PDF

Mutations disrupting the kinase domain of IKKα lead to immunodeficiency and immune dysregulation in humans.

J Exp Med

February 2025

Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, Imagine Institute, University Paris Cité, Paris, France.

IKKα, encoded by CHUK, is crucial in the non-canonical NF-κB pathway and part of the IKK complex activating the canonical pathway alongside IKKβ. The absence of IKKα causes fetal encasement syndrome in humans, fatal in utero, while an impaired IKKα-NIK interaction was reported in a single patient and causes combined immunodeficiency. Here, we describe compound heterozygous variants in the kinase domain of IKKα in a female patient with hypogammaglobulinemia, recurrent lung infections, and Hay-Wells syndrome-like features.

View Article and Find Full Text PDF

G-Protein Coupled Receptor, Class C, Group 5, Member A (GPRC5A) has been extensively studied in lung and various epithelial cancers. Nevertheless, its role in the skin remains to be elucidated. In this study, we sought to investigate the function of this receptor in skin biology.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is marked by extracellular beta-amyloid (Aβ) plaques and intracellular Tau tangles, leading to progressive cognitive decline and neuronal dysfunction. Impaired autophagy, a process by which a cell breaks down and destroys damaged or abnormal proteins and other substances, contributes to AD progression. This study investigated Nuclear Receptor Subfamily 1 Group D Member 1 (NR1D1) as a potential therapeutic target for modulating autophagy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!